← Leaderboards
Philip L Fuchs
Purdue University West Lafayette
$3,677,630
Attributed
$3,677,630
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $407.5K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$3,677,630 · 2
By mechanism
R01$1,869,493 · 1
U01$1,808,137 · 1
Top collaborators
No co-investigators on record.
Most similar at Purdue University West Lafayette
Same institution · by research overlap
- David H Thompson$5,071,013
- Rashid Bashir$13,104,330
- Janet L Smith$23,647,105
- Philip Stewart Low$12,952,450
Others in their field
Top investigators on “Folate”
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Brian E Henderson · University Of Southern California$20,353,887
- Ulrike Peters · Fred Hutchinson Cancer Research Center$18,907,654
- James F Toole · Wake Forest University Health Sciences$17,951,480
- John Anthony Baron · Dartmouth College$17,250,532
- Loic Le Marchand · University Of Hawaii At Manoa$17,180,480
Research focus
FolateDrug Design /Synthesis /ProductionGeranyl CompoundSteroid AnalogAffinity LabelingAntineoplasticsPyrazinesOncogenesVinyl EtherSteroid BiosynthesisNucleobase AnalogCancer CenterBiotinCell LineBiologyAntineoplastic AgentsAnalogAnticancer ActivityCovalent BondCollaborationsCovalent InteractionBiologicalDipeptidesBiochemical
Grant awards (12)
Synthesis & Mechanism of Cephalostatin Anticancer Drugs$392,765
U01 · FY2009 · CA · contact PI
Synthesis & Mechanism of Cephalostatin Anticancer Drugs$396,784
U01 · FY2008 · CA · contact PI
Synthesis & Mechanism of Cephalostatin Anticancer Drugs$407,547
U01 · FY2007 · CA · contact PI
Synthesis & Mechanism of Cephalostatin Anticancer Drugs$292,419
U01 · FY2006 · CA · contact PI
Synthesis &Mechanism of Cephalostatin Anticancer Drugs$318,622
U01 · FY2005 · CA
ONCOGENE DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUG$368,365
R01 · FY2004 · CA
ONCOGENE DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUG$357,778
R01 · FY2003 · CA
ONCOGENE DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUG$347,503
R01 · FY2002 · CA
ONCOGENE DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUG$337,525
R01 · FY2001 · CA
ONCOGENE DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUG$64,933
R01 · FY2001 · CA
ONCOGENE DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUG$31,649
R01 · FY2001 · CA
ONCOGENE DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUG$361,740
R01 · FY2000 · CA